Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Experimental Hematology

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.EXPHEM.2003.11.007PMID 15102478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of stem cells in aging.

  2003cited by this paper
• Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors

  2002cited by this paper
• The aging of lympho-hematopoietic stem cells

  2002cited by this paper
• Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution.

  2002cited by this paper
• Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.

  2002cited by this paper
• Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy.

  2001cited by this paper
• Growth hormone (GH), GH receptor, and signal transduction.

  2000cited by this paper
• Diversification of haematopoietic stem cells to specific lineages

  2000cited by this paper
• Growth hormone as an immunomodulating therapeutic agent.

  2000cited by this paper
• Genetic regulation of primitive hematopoietic stem cell senescence.

  2000cited by this paper
• Stem Cells Units of Development, Units of Regeneration, and Units in Evolution

  2000cited by this paper
• PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis.

  1999cited by this paper
• Dynamic changes in mouse hematopoietic stem cell numbers during aging.

  1999cited by this paper
• Homing and mobilization in the stem cell niche.

  1999cited by this paper
• Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.

  1999cited by this paper
• Development and aging of primitive hematopoietic stem cells in BALB/cBy mice.

  1999cited by this paper
• Dynamic Changes in Mouse Hematopoietic Stem Cell Numbers During Aging

  1999cited by this paper
• The Haematopoietic Effects of Growth Hormone and Insulin-like Growth Factor-I

  1998cited by this paper
• Recombinant Human Growth Hormone Promotes Hematopoietic Reconstitution after Syngeneic Bone Marrow Transplantation in Mice

  1998cited by this paper
• The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.

  1997cited by this paper
• In vitro maintenance of highly purified, transplantable hematopoietic stem cells.

  1997cited by this paper
• Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim

  1997cited by this paper
• Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors

  1997cited by this paper
• Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term.

  1997cited by this paper
• Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy

  1997cited by this paper
• Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.

  1996cited by this paper
• STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACY

  1996cited by this paper
• The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency

  1996cited by this paper
• The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts.

  1996cited by this paper
• Ontogeny-related changes in proliferative potential of human hematopoietic cells

  1993cited by this paper
• Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo.

  1992cited by this paper
• Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymidine.

  1992cited by this paper
• Long‐term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time

  1990cited by this paper
• Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.

  1989cited by this paper
• Regulation of hemopoietic cell growth and development: experimental and clinical studies.

  1989cited by this paper
• Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin‐like growth factor I

  1988cited by this paper
• UKCCCR guidelines for the welfare of animals in experimental neoplasia.

  1988cited by this paper
• Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.

  1988cited by this paper
• Granulopoiesis in aged people: inverse correlation between bone marrow cellularity and myeloid progenitor cell numbers.

  1987cited by this paper
• Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation.

  1985cited by this paper
• Characterization of a primitive erythropoietic progenitor found in mouse marrow before and after several weeks in culture.

  1979cited by this paper
• Growth hormone: species-specific stimulation of erythropoiesis in vitro.

  1977cited by this paper

• Single Apheresis Session on the 4th Day of Granulocyte Colony-Stimulating Factor Administration Seems Convenient to Collect Enough Peripheral Blood Stem Cells from Healthy Donors

  2024cites this paper
• The potential role of the thymus in immunotherapies for acute myeloid leukemia

  2023cites this paper
• Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization?

  2023cites this paper
• Dynamics of thymus function and T cell receptor repertoire breadth in health and disease

  2021cites this paper
• Growth Hormone Deficiency: Is It Just a Problem of Growth Impairment? Part II

  2020influential citation
• T cell regeneration after immunological injury

  2020cites this paper
• Growth Hormone Deficiency: Is It Just a Problem of Growth Impairment? Part I

  2019cites this paper
• Strategies to Improve Posttransplant Immunity

  2019cites this paper
• Development of a sandwich enzyme-linked immunosorbent assay for dTMP-GH fusion protein by rational immunogen selection

  2017cites this paper
• Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?

  2016cites this paper
• Immune Reconstitution Following Hematopoietic Cell Transplantation

  2016cites this paper
• Growth Hormone Protects the Intestine Preserving Radiotherapy Efficacy on Tumors: A Short-Term Study

  2015cites this paper
• hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesis.

  2014cites this paper
• Growth hormone receptor signaling is dispensable for HSC function and aging.

  2014cites this paper
• aging Growth hormone receptor signaling is dispensable for HSC function and

  2014cites this paper
• Predictors of the yield of mobilized peripheral blood CD34+ cells in HLA-matched sibling donor.

  2013cites this paper
• The Immunological Barriers to Regenerative Medicine

  2013cites this paper
• blockade SOCS up-regulation mobilizes autologous stem cells through CXCR4

  2013cites this paper
• The immunogenicity of stem cells and thymus-based strategies to minimise immune rejection

  2013cites this paper
• Strategies to improve post-transplant immunity

  2013cites this paper
• Rational and efficient preparation of a chimeric protein containing a tandem dimer of thrombopoietin mimetic peptide fused to human growth hormone in Escherichia coli

  2012cites this paper
• Oxidative stress due to radiation in CD34+ Hematopoietic progenitor cells: protection by IGF-1

  2012cites this paper
• Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation.

  2011cites this paper
• Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease?

  2010cites this paper
• Mobilization of Hematopoietic Cells Prior to Autologous or Allogeneic Transplantation

  2010cites this paper
• The Role of Steroids in Endothelial Function in the Ageing Male

  2010cites this paper
• Osteogenic hormones acting on the environment of the hematopoietic stem cell niche

  2009cites this paper
• Stem cells—meet immunity

  2009cites this paper
• Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide.

  2009cites this paper
• Effects of Human Growth Hormone on Haematopoietic Recovery of Rats Receiving Chemotherapy

  2008cites this paper
• Growth hormone enhances thymic function in HIV-1-infected adults.

  2008cites this paper
• The role of sex steroids and gonadectomy in the control of thymic involution.

  2008cites this paper
• Abdominal radiation initiates apoptotic mechanism in rat femur bone marrow cells in vivo that is reversed by IGF-1 administration.

  2008cites this paper
• Methods to fuse macrophages in vitro.

  2008cites this paper
• On experimental design and discourse in plasticity research

  2007cites this paper
• Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I.

  2007influential citation
• Development of novel prolactin and growth hormone receptor agonists and antagonists

  2007cites this paper
• Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1

  2007cites this paper
• Thymic hyperplasia in a child treated with growth hormone.

  2007cites this paper
• Placental Growth Factor‐1 Potentiates Hematopoietic Progenitor Cell Mobilization Induced by Granulocyte Colony‐Stimulating Factor in Mice and Nonhuman Primates

  2007cites this paper
• Cytokines and hematopoietic stem cell mobilization

  2006cites this paper
• SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade.

  2006cites this paper
• The oncogenic potential of growth hormone.

  2006cites this paper
• Growth Hormone–Induced Stimulation of Multilineage Human Hematopoiesis

  2005cites this paper
• Hematopoiesis.

  2005cites this paper
• Factors associated with granulocyte colony‐stimulating factor‐induced peripheral blood stem cell yield in healthy donors

  2005cites this paper
• Mice severely deficient in growth hormone have normal hematopoiesis.

  2005cites this paper
• CXCR4-mediated Suppressor of Cytokine Signaling Up-regulation Inactivates Growth Hormone Function*

  2004cites this paper
• Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.

  2004cites this paper
• PBSC mobilization.

  2004cites this paper